Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kaluga Sales Company reported for 6 months of 2024 by RAS

7/30/24 KLSB

UTair reports for 6 months of 2024 under RAS

7/30/24 UTAR

VTB reported for 6 months of 2024 by IFRS

7/30/24 VTBR

Yandex will start paying dividends

7/30/24 YDEX

Yandex reported for 6 months of 2024 by IFRS

7/30/24 YDEX

Kamchatskenergo reported for 6 months of 2024 by RAS

7/30/24 KCHE

ICPAO Headhunter to launch new HeadHunter receipt exchange

7/30/24 HEAD

Samaraenergo reported for 6 months of 2024 by RAS

7/29/24 SAGO

TNS Energo Voronezh reported for 6 months of 2024 by RAS

7/29/24 VRSB

TNS Energo Rostov-on-Don reported for 6 months of 2024 by RAS

7/29/24 RTSB